aTyr Pharma Inc (LIFE)
1.56
-0.04
(-2.50%)
USD |
NASDAQ |
Apr 25, 09:54
aTyr Pharma Price to Book Value: 1.166 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.196 |
| April 23, 2024 | 1.211 |
| April 22, 2024 | 1.226 |
| April 19, 2024 | 1.196 |
| April 18, 2024 | 1.211 |
| April 17, 2024 | 1.188 |
| April 16, 2024 | 1.203 |
| April 15, 2024 | 1.270 |
| April 12, 2024 | 1.300 |
| April 11, 2024 | 1.315 |
| April 10, 2024 | 1.323 |
| April 09, 2024 | 1.285 |
| April 08, 2024 | 1.368 |
| April 05, 2024 | 1.39 |
| April 04, 2024 | 1.398 |
| April 03, 2024 | 1.382 |
| April 02, 2024 | 1.375 |
| April 01, 2024 | 1.427 |
| March 28, 2024 | 1.457 |
| March 27, 2024 | 1.495 |
| March 26, 2024 | 1.431 |
| March 25, 2024 | 1.435 |
| March 22, 2024 | 1.457 |
| March 21, 2024 | 1.510 |
| March 20, 2024 | 1.510 |
| Date | Value |
|---|---|
| March 19, 2024 | 1.495 |
| March 18, 2024 | 1.461 |
| March 15, 2024 | 1.487 |
| March 14, 2024 | 1.211 |
| March 13, 2024 | 1.218 |
| March 12, 2024 | 1.131 |
| March 11, 2024 | 1.117 |
| March 08, 2024 | 1.110 |
| March 07, 2024 | 1.159 |
| March 06, 2024 | 1.187 |
| March 05, 2024 | 1.166 |
| March 04, 2024 | 1.250 |
| March 01, 2024 | 1.333 |
| February 29, 2024 | 1.340 |
| February 28, 2024 | 1.326 |
| February 27, 2024 | 1.396 |
| February 26, 2024 | 1.354 |
| February 23, 2024 | 1.333 |
| February 22, 2024 | 1.319 |
| February 21, 2024 | 1.375 |
| February 20, 2024 | 1.312 |
| February 16, 2024 | 1.410 |
| February 15, 2024 | 1.344 |
| February 14, 2024 | 1.340 |
| February 13, 2024 | 1.333 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3604
Minimum
Aug 14 2019
8.437
Maximum
Sep 23 2021
1.197
Average
1.080
Median
Price to Book Value Benchmarks
| Vaxart Inc | 2.105 |
| Allogene Therapeutics Inc | 0.9573 |
| AIM ImmunoTech Inc | 2.248 |
| Protalix BioTherapeutics Inc | 2.546 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 1.56 |
| Earnings Yield | -61.54% |
| Market Cap | 105.69M |